Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.50
Bid: 99.00
Ask: 100.00
Change: 0.50 (0.51%)
Spread: 1.00 (1.01%)
Open: 99.00
High: 101.00
Low: 99.00
Prev. Close: 99.00
OMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Jul 2008 13:18

RNS Number : 8144Z
OMG PLC
24 July 2008
 



24 July 2008

OMG plc ("OMG" or "the Company")

Notifiable Interest

The Company was notified today by Tom Shannon that he has sold 100,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company. Following this transaction, Mr Shannon no longer holds a notifiable interest in the Company.

For further information please contact:

 

OMG plc

01865 261800

Nick Bolton, Chief Executive

 

Evolution Securities

020 7071 4300

Jeremy Ellis / Louise McGolpin

 

Financial Dynamics

020 7831 3113

Juliet Clarke / Matt Dixon

 

 

 

 

 

Notes to Editors

 

About OMG

OMG plc (Oxford Metrics Group. LSE: OMG) is a group of technology companies producing image understanding products and services for the entertainment, defence, life science and engineering industries. Be it for capturing the movements of actors (for the movie industry), sportsmen (for video games or improving team performance), children with Cerebral Palsy, rehab patients and animals (for medical, life science and research industries) or virtual reality displays (for engineering and development), the Group has the world leading market position and a strong international reputation for precision instruments.

 

Founded in 1984, the Group's headquarters are in OxfordUK, and it has offices in California and ColoradoUSA. It has customers in over 50 countries and is a quoted company listed on AIM, a market operated by the London Stock Exchange. The Group trades through three operating subsidiaries - Vicon, the world's biggest motion capture and movement analysis company, 2d3, a manufacturer of specialised image understanding software for entertainment and defence applications and Yotta, our 3D mapping business, which collects and analyses highway data and street level imaging and which, following the acquisition of DCL in July 2007, offers the most accurate and complete highway survey available.

 

Oxford Metrics' global clients in science, medicine, sport, engineering, gaming, film, broadcast and 3D mapping include major hospitals and research facilities such as Guy's Hospital, Nuffield Orthopaedic Centre and Loughborough University, engineering industry leaders including Ford Motor Company, BMW, Airbus and Toyota, and in the entertainment sector, Sony, Industrial Light and Magic, The Moving Picture Company (MPC), Sega, Nintendo, UbiSoft, EA, Square Enix and in 3D mapping and highway surveys: Mouchel Parkman, Atkins, and Oxfordshire, Cumbria, Derbyshire and Pembrokeshire County Councils as well as many others. 

 

For more information about OMG and its subsidiaries, visit www.omg3d.com, www.vicon.com, www.2d3.com or www.yotta.tv

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSESFELSASEFW
Date   Source Headline
11th Jun 20247:00 amRNSInterim Results
15th May 20247:00 amRNSNotice of Results and Investor Presentation
14th May 20243:46 pmRNSHolding(s) in Company
18th Apr 20247:00 amRNSCapital Markets Day
25th Mar 20244:50 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSChange in CFO
13th Feb 20243:49 pmRNSGrant of LTIP Awards to Directors
6th Feb 20244:31 pmRNSPDMR Shareholding
31st Jan 20243:35 pmRNSResult of AGM
31st Jan 20242:00 pmRNSAGM Statement and Notice of CMD
13th Dec 20235:24 pmRNSPosting Annual Report & Accounts and Notice of AGM
12th Dec 20237:00 amRNSIssue of Ordinary Shares & Total Voting Rights
8th Dec 20237:00 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSPreliminary Results
20th Nov 20237:00 amRNSInvestor Presentation
1st Nov 20237:00 amRNSAcquisition of Industrial Vision Systems Ltd
25th Oct 20237:00 amRNSTrading Update
11th Oct 202310:42 amRNSHolding(s) in Company
6th Oct 202312:44 pmRNSHolding(s) in Company
2nd Oct 20237:00 amRNSConfirmation of CEO Appointment
10th Jul 20237:00 amRNSCEO Succession
20th Jun 20237:00 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
15th Jun 202310:34 amRNSIssue of Ordinary Shares & Total Voting Rights
6th Jun 20237:00 amRNSInterim Results
25th May 202311:59 amRNSInvestor Presentation
17th May 20237:00 amRNSVicon contract win
12th May 20237:00 amRNSNotification of Results
13th Feb 20232:15 pmRNSPDMR Shareholding and Director Dealing
9th Feb 20232:59 pmRNSResult of AGM
9th Feb 20237:00 amRNSAGM Statement
17th Jan 202311:22 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
22nd Dec 20227:00 amRNSDividend update
16th Dec 202211:39 amRNSIssue of Ordinary Shares & Total Voting Rights
13th Dec 20225:51 pmRNSPosting Annual Report & Accounts and Notice of AGM
9th Dec 202211:20 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
6th Dec 20225:06 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
6th Dec 20227:00 amRNSPreliminary Results
28th Nov 20227:00 amRNSInvestor Presentation
9th Nov 20227:00 amRNSNotice of Results
27th Sep 20227:00 amRNSTrading Update
17th Aug 20227:00 amRNSVicon Contract Win
28th Jul 202212:46 pmRNSIssue of Ordinary Shares & Total Voting Rights
20th Jul 20227:00 amRNSIssue of Ordinary Shares & Total Voting Rights
19th Jul 202212:42 pmRNSIssue of Ordinary Shares & Total Voting Rights
19th Jul 20227:00 amRNSVicon launches new Valkyrie solution
5th Jul 20225:04 pmRNSHolding(s) in Company
4th Jul 20225:53 pmRNSExercise of Options, Director Dealing and TVR
24th Jun 20227:00 amRNSIssue of Ordinary Shares & Total Voting Rights
23rd Jun 20227:00 amRNSInterim Results
7th Jun 20227:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.